Genetic analysis of exopolysaccharide acetilation product by Burkholderia cepacia


Submitted: 13 February 2014
Accepted: 13 February 2014
Published: 30 June 2012
Abstract Views: 815
PDF: 794
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Bacteria belonging to the Burkholderia cepacia complex are mainly isolated from the sputum of cystic fibrosis patients and frequently show a mucoid phenotype.Most of them produce an exopolysaccharide called cepacian, whose repeating unit consists of a branched heptasaccharide carrying from one to three acetyl esters. Two genetic loci, bceI and bceII, consisting of 11 and 9 genes respectively, are involved in cepacian biosynthesis.Three genes located in the bceII locus, named bceOSU, code for different acyltransferases. As the presence of acetyl groups influences the viscosity of cepacian, we compared three strains (two clinical isolates named BTS2 and BTS7, and the reference strain Burkholderia sp. 383) exhibiting differences both in the acetylation pattern and at the genomic level, for the presence of insertion sequences adjacent to bceU.

Furlanis, L., Corich, L., Gon, F., Tonin, E. A., Dolzani, L., & Lagatolla, C. (2012). Genetic analysis of exopolysaccharide acetilation product by Burkholderia cepacia. Microbiologia Medica, 27(2). https://doi.org/10.4081/mm.2012.2319

Downloads

Download data is not yet available.

Citations